{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:30:25Z","timestamp":1775835025768,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:00:00Z","timestamp":1440806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23590112"],"award-info":[{"award-number":["23590112"]}]},{"name":"JSPS KAKENHI","award":["26460103"],"award-info":[{"award-number":["26460103"]}]},{"name":"MEXT KAKENHI","award":["23122517"],"award-info":[{"award-number":["23122517"]}]},{"name":"MEXT KAKENHI","award":["25122712"],"award-info":[{"award-number":["25122712"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jphs.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T02:02:57Z","timestamp":1441332177000},"page":"107-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Retinal region-dependent susceptibility of capillaries to high-concentration oxygen exposure and vascular endothelial growth\u00a0factor receptor inhibition in neonatal mice"],"prefix":"10.1016","volume":"129","author":[{"given":"Naoto","family":"Iizuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Ushikubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2015.08.010_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1387\/ijdb.041895ms","article-title":"Development and pathology of the hyaloid, choroidal and retinal vasculature","volume":"48","author":"Saint-Geniez","year":"2004","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.jphs.2015.08.010_bib2","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2015.08.010_bib3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","article-title":"Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy","volume":"246","author":"Moradian","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jphs.2015.08.010_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1651-2227.2011.02330.x","article-title":"On the use of antiangiogenetic medications for retinopathy of prematurity","volume":"100","author":"H\u00e5rd","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jphs.2015.08.010_bib5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jphs.2015.08.010_bib6","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on m\u00fcller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2015.08.010_bib7","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2015.08.010_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jphs.2015.08.010_bib9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2015.08.010_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00417-009-1116-4","article-title":"Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jphs.2015.08.010_bib11","first-page":"222","article-title":"Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice","volume":"42","author":"Brooks","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2015.08.010_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.exer.2009.12.012","article-title":"Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy","volume":"90","author":"Uno","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2015.08.010_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2015.01.052","article-title":"17\u03b2-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase","volume":"457","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2015.08.010_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jphs.2015.08.010_bib15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","article-title":"A\u00a0plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF","volume":"125","author":"Benjamin","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.jphs.2015.08.010_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-4835(03)00153-2","article-title":"Role of arteries in oxygen induced vaso-obliteration","volume":"77","author":"Claxton","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2015.08.010_bib17","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2015.08.010_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1076\/ceyr.18.1.20.5390","article-title":"Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy","volume":"18","author":"Higgins","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jphs.2015.08.010_bib19","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1182\/blood-2010-08-302067","article-title":"The Dll4\/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow","volume":"117","author":"Lobov","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jphs.2015.08.010_bib20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1248\/bpb.b14-00487","article-title":"Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy","volume":"37","author":"Yagasaki","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jphs.2015.08.010_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exer.2014.01.009","article-title":"Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice","volume":"120","author":"Morita","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2015.08.010_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","article-title":"Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts","volume":"165","author":"Inai","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jphs.2015.08.010_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","article-title":"Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization","volume":"156","author":"Ozaki","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jphs.2015.08.010_bib24","first-page":"496","article-title":"Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity","volume":"43","author":"Gu","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2015.08.010_bib25","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"He","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2015.08.010_bib26","doi-asserted-by":"crossref","first-page":"H547","DOI":"10.1152\/ajpheart.00616.2005","article-title":"Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling","volume":"290","author":"Baffert","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315001930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861315001930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T11:07:33Z","timestamp":1653131253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861315001930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1347861315001930"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2015.08.010","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal region-dependent susceptibility of capillaries to high-concentration oxygen exposure and vascular endothelial growth\u00a0factor receptor inhibition in neonatal mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}